Zofran 2 mg/ml raztopina za injiciranje/infundiranje Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zofran 2 mg/ml raztopina za injiciranje/infundiranje

novartis pharma gmbh - ondansetron - raztopina za injiciranje/infundiranje - ondansetron 2 mg / 1 ml - ondansetron

Budesonide/Formoterol Teva Pharma B.V. Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

budesonide/formoterol teva pharma b.v.

teva pharma b.v. - budesonide, formoterol - astma - zdravila za obstruktivne pljučne bolezni, - budezonid / formoterol teva pharma b. je indiciran pri odraslih, starih samo 18 let ali več. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.

Tybost Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

tybost

gilead sciences ireland uc - cobicistat - okužbe z virusom hiv - antivirusi za sistemsko uporabo - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

Travatan Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

travatan

novartis europharm limited - travoprost - glaucoma, open-angle; ocular hypertension - oftalmologi - zmanjšanje zvišanega očesnega tlaka pri odraslih bolnikih z očesno hipertenzijo ali glavkomom odprtega zakotja (glejte poglavje 5. znižanje zvišanega očesnega tlaka pri pediatričnih bolnikih, starih od 2 mesecev do < 18 let, s očesni hipertenzije ali pediatričnih glavkoma (glej poglavje 5.

Namuscla Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

namuscla

lupin europe gmbh - mexiletine hydrochloride - myotonic motnje - srčna terapija - namuscla je primerna za simptomatsko zdravljenje myotonia pri odraslih bolnikih z ne-dystrophic myotonic motnje.